GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » Cyclically Adjusted PS Ratio

Ferozsons Laboratories (KAR:FEROZ) Cyclically Adjusted PS Ratio : 1.23 (As of May. 29, 2025)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories Cyclically Adjusted PS Ratio?

As of today (2025-05-29), Ferozsons Laboratories's current share price is ₨311.80. Ferozsons Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₨253.51. Ferozsons Laboratories's Cyclically Adjusted PS Ratio for today is 1.23.

The historical rank and industry rank for Ferozsons Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

KAR:FEROZ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.71   Med: 1.13   Max: 1.6
Current: 1.25

During the past years, Ferozsons Laboratories's highest Cyclically Adjusted PS Ratio was 1.60. The lowest was 0.71. And the median was 1.13.

KAR:FEROZ's Cyclically Adjusted PS Ratio is ranked better than
67.57% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs KAR:FEROZ: 1.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ferozsons Laboratories's adjusted revenue per share data for the three months ended in Mar. 2025 was ₨117.171. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₨253.51 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ferozsons Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Ferozsons Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories Cyclically Adjusted PS Ratio Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.10

Ferozsons Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.10 1.23 1.38 1.22

Competitive Comparison of Ferozsons Laboratories's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Cyclically Adjusted PS Ratio falls into.


;
;

Ferozsons Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ferozsons Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=311.80/253.51
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Ferozsons Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=117.171/134.9266*134.9266
=117.171

Current CPI (Mar. 2025) = 134.9266.

Ferozsons Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 47.239 100.684 63.305
201509 69.598 100.392 93.540
201512 79.215 99.792 107.104
201603 66.005 100.470 88.641
201606 45.024 101.688 59.741
201609 30.660 101.861 40.613
201612 30.719 101.863 40.690
201703 24.022 102.862 31.510
201706 29.731 103.349 38.815
201709 23.920 104.136 30.993
201712 33.425 104.011 43.360
201803 30.250 105.290 38.765
201806 27.202 106.317 34.522
201809 27.895 106.507 35.338
201812 33.383 105.998 42.494
201903 32.036 107.251 40.303
201906 40.049 108.070 50.002
201909 30.784 108.329 38.342
201912 35.035 108.420 43.600
202003 40.919 108.902 50.698
202006 36.205 108.767 44.913
202009 34.680 109.815 42.610
202012 50.290 109.897 61.744
202103 53.989 111.754 65.184
202106 65.288 114.631 76.847
202109 51.144 115.734 59.625
202112 49.971 117.630 57.319
202203 58.751 121.301 65.350
202206 54.686 125.017 59.021
202209 59.128 125.227 63.708
202212 61.586 125.222 66.359
202303 72.289 127.348 76.591
202306 71.062 128.729 74.483
202309 101.834 129.860 105.808
202312 88.886 129.419 92.668
202403 86.084 131.776 88.142
202406 87.652 132.554 89.221
202409 104.186 133.029 105.672
202412 108.798 133.157 110.244
202503 117.171 134.927 117.171

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ferozsons Laboratories  (KAR:FEROZ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ferozsons Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines